Another Major Drug Approval for Regeneron
Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
Similar News Items
Congratulations to BCW Member Clarapath, a medical robotics company transforming the way pathology laboratories process tissue, which announced this week it has entered into a strategic collaboration with Mayo Clinic to propel a new era of laboratory automation. For decades, laboratories have relied on labor intensive, manual procedures to process tissue specimens for purposes of […]
Two of Westchester’s significant transformational projects — Standard Amusements Playland and Empire City Casino by MGM Resorts — were the focus of a highly informative Business Council of Westchester State of Economy forum held April 11. Featured speakers were Evonne Keeler, CEO of Standard Amusements Playland and Taryn Duffy, Vice President of Public Affairs at […]
The Rising Stars Leadership Council and the Rising Stars Alumni partnered with Neighbors Link to increase awareness about their mission. Each year, the BCW’s Rising Stars Alumni Not-For-Profit Partnership focuses their support on not-for-profits that have Rising Stars Winners. For the 2023-2024 Partnership, in addition to Neighbors Link, other not-for-profit partners include Feeding Westchester; the […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.